Tomić, T.; Tomić, D.; Vukoja, M.; Kraljević, M.; Ljevak, I.; Glamočlija, U.; Tomić, V.; Vukojević, K.; Beljan Perak, R.; Šoljić, V.
Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib. Biomedicines 2024, 12, 149.
https://doi.org/10.3390/biomedicines12010149
AMA Style
Tomić T, Tomić D, Vukoja M, Kraljević M, Ljevak I, Glamočlija U, Tomić V, Vukojević K, Beljan Perak R, Šoljić V.
Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib. Biomedicines. 2024; 12(1):149.
https://doi.org/10.3390/biomedicines12010149
Chicago/Turabian Style
Tomić, Tanja, Davor Tomić, Martina Vukoja, Marija Kraljević, Ivona Ljevak, Una Glamočlija, Vajdana Tomić, Katarina Vukojević, Renata Beljan Perak, and Violeta Šoljić.
2024. "Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib" Biomedicines 12, no. 1: 149.
https://doi.org/10.3390/biomedicines12010149
APA Style
Tomić, T., Tomić, D., Vukoja, M., Kraljević, M., Ljevak, I., Glamočlija, U., Tomić, V., Vukojević, K., Beljan Perak, R., & Šoljić, V.
(2024). Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib. Biomedicines, 12(1), 149.
https://doi.org/10.3390/biomedicines12010149
